A recent paper showed that PACAP can alleviate inflammation and steatosis, thus it can be protective in obesity-related hepatic pathology and can ameliorate glucose and lipid metabolism (66). The gene discussed is ADCYAP1; the disease is obesity due to melanocortin 4 receptor deficiency.